3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
19
Unknown
3
Terminated
3
Recruiting
3
Active not recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
2
Genitourinary
1
Conditions
Breast Neoplasms
2
Prostatic Neoplasms
1
Neuritis
1
Interventions
Cyclophosphamide
389
Carboplatin
343
Gemcitabine
331
pembrolizumab
328
Cisplatin
327
Paclitaxel
294
Radiotherapy
291
Docetaxel
285
Bevacizumab
249
Rituximab
233
Capecitabine
221
Nivolumab
218
Dexamethasone
205
Fluorouracil
189
fludarabine
177
Oxaliplatin
177
Pemetrexed
153
Doxorubicin
152
Irinotecan
147
Etoposide
144
Leucovorin
143
Cytarabine
133
Bortezomib
129
fludarabine phosphate
128
Cetuximab
126
Lenalidomide
125
Filgrastim
119
Erlotinib Hydrochloride
119
Temozolomide
111
Radiosurgery
110
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
Interventional
×
Massage
×
Clear all
NCT04202640
2026-03-18
PRESSODOU
Centre Oscar Lambret
Phase NA
Terminated
80 enrolled
NCT05067777
2025-12-15
mPROSTATE
University of Utah
Phase 2
Terminated
28 enrolled
NCT03557554
2019-08-26
PIPN
Indiana University
Phase NA
Terminated
5 enrolled